385
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Factors Influencing Adherence to Treatment and Quality of Life for a Group of Patients with Essential Hypertension in Romania

ORCID Icon, , ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & show all
Pages 483-491 | Published online: 26 Feb 2021

References

  • World Health Organization. International classification of functioning, disability and health; 2001. Available from: https://www.who.int/docs/default-source/classification/icf/official-icf-updates/2011icfupdates.pdf?sfvrsn=485cb584_2. Accessed December 20, 2020.
  • Carvalho MA, Silva IB, Ramos SB, et al. Quality of life of hypertensive patients and comparison of two instruments of HRQoL measure. Arq Bras Cardiol. 2012;98:442–510. doi:10.1590/S0066-782X2012005000032
  • Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67–74. doi:10.1097/00005650-198601000-00007
  • Korb-Savoldelli V, Gillaizeau F, Pouchot J, et al. Validation of a French version of the 8-item Morisky medication adherence scale in hypertensive adults. J Clin Hypertens (Greenwich). 2012;14:429–434. doi:10.1111/j.1751-7176.2012.00634.x
  • Melchiors AC, Correr CJ, Pontarolo R, et al. Quality of life in hypertensive patients and concurrent validity of Minichal-Brazil. Arq Bras Cardiol. 2010;94:337–344. doi:10.1590/s0066-782x2010000300013
  • Dorobantu M, Tautu OF, Dimulescu D, et al. Perspectives on hypertension prevalence treatment and control in a high cardiovascular risk East European country (data from the Sephar III survey). J Hypertens. 2018;36:690–700. doi:10.1097/HJH.0000000000001572
  • Dorobantu M, Darabont R, Dimulescu D, et al. New epidemiologic national representative survey. Sephar III main results. J Hypertens. 2017;35:pe60. doi:10.1097/01.hjh.0000523132.85277.15
  • Dorobantu M, Darabont RO, Badila E, et al. Prevalence, awareness, treatment and control of hypertension in Romania: results of the Sephar Study. Int J Hypertens. 2010;2010:970694. doi:10.4061/2010/970694
  • Dorobantu M, Darabont R, Ghiorghe S, et al. Hypertension prevalence and control in Romania at a seven-year interval. Comparison of Sephar I and II surveys. J Hypertens. 2014;32:39–47. doi:10.1097/01.hjh.0000434937.62412.24
  • Dorobanţu M, Bartoş D, Apetrei E, et al. Hypertension in Romania: where are we and what can we do? Results from SEPHAR II study. Rom J Cardiol. 2012;22:285–292.
  • Rana BK, Insel PA, Payne SH, et al. Population-based sample reveals gene-gender interactions in blood pressure in White Americans. Hypertension. 2007;49:96–106. doi:10.1161/01.HYP.0000252029.35106.67
  • Mancia G, Fagard R, Narkiewicz K, et al. Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31:1281–1357. doi:10.1097/01.hjh.0000431740.32696.cc
  • Williams B, Mancia G, Spiering W, et al. ESC/ESH guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Cardiology ESC and the European Society of Hypertension ESH. J Hypertens. 2018;37:1953–2041.
  • Ogilvie RI, Anand S, Roy P, et al. Perindopril for control of blood pressure in patients with hypertension and other risk factors: an open label, observational, multicentre, general-practice-based study. Clin Drug Investig. 2008;28:673–686. doi:10.2165/00044011-200828110-00001
  • Mourad JJ, Le Jeune S. Evaluation of high dose of perindopril/indapamide fixed combination in reducing blood pressure and improving end-organ protection in hypertensive patients. Curr Med Res Opin. 2009;25:2271–2280. doi:10.1185/03007990903186787
  • Ross S, Walker A, MacLeod MJ. Patient compliance in hypertension: role of illness perceptions and treatment beliefs. J Hum Hypertens. 2004;18:607–613. doi:10.1038/sj.jhh.1001721
  • Abbas H, Kurdi M, Watfa M, et al. Adherence to treatment and evaluation of disease and therapy knowledge in Lebanese hypertensive patients. Patient Prefer Adherence. 2017;11:1949–1956. doi:10.2147/PPA.S142453
  • Katsi V, Kallistratos MS, Kontoangelos K, et al. Arterial hypertension and health related quality of life. Front Psychiatry. 2017;8:270. doi:10.3389/fpsyt.2017.00270
  • Cavalcante MA, Bombiq MT, Luna Filho B, et al. Quality of life of hypertensive patients treated at an outpatient clinic. Arq Bras Cardiol. 2007;89:245–250. doi:10.1590/s0066-782x2007001600006
  • Xiao M, Zhang F, Xiao N, et al. Health-related quality of life of hypertension patients: a population based cross sectional study in Chongqing, China. Int J Environ Res Public Health. 2019;16:2348. doi:10.3390/ijerph16132348
  • Youssef RM, Moubarak II, Kamel MI. Factors affecting the quality of life of hypertensive patients. East Mediterr Health J. 2005;11:109–118.
  • Cuffee Y, Ogedegbe C, Williams NJ, et al. Psychosocial risk factors for hypertension. An update of the literature. Curr Hypertens Rep. 2014;16:483. doi:10.1007/s11906-014-0483-3
  • Bacon SL, Campbell TS, Arsenault A, et al. The impact of mood and anxiety disorders on incident hypertension at one year. Int J Hypertens. 2014;2014:953094. doi:10.1155/2014/953094
  • Osman EM, Suleiman I, Elzubair AG. Patients knowledge of hypertension and its control in Eastern Sudan. East Afr Med J. 2007;84:324–328. doi:10.4314/eamj.v84i7.9587
  • Vierra AJ, Cohen LW, Mitchell CM, et al. High blood pressure knowledge among primary care patients with known hypertension: a North Carolina Family Medicine Research Network (NC-FMR-RN) study. J Am Board Fam Med. 2008;21:300–308. doi:10.3122/jabfm.2008.04.070254
  • Ho PM, Bryson CL, Rumsfeld JS. Medication adherence: its importance in cardiovascular outcomes. Circulation. 2009;119:3028–3035. doi:10.1161/CIRCULATIONAHA.108.768986